Medical Bulletin 05/September/2025 Dr. Bhumika Maikhuri5 Sept 2025 3:00 PM ISTHere are the top medical news for the day:Artificial Sweeteners Could Speed Up Brain Aging by 1.6 Years: Study FindsConsuming large amounts of...
New Urine Test May Detect Prostate Cancer with 91 Percent Accuracy: Study Dr. Bhumika Maikhuri5 Sept 2025 8:30 AM ISTIn a new study, researchers have developed a novel urine-based test to detect prostate cancer. The findings were published in eBioMedicine. Prostate...
Chinese Medical Journal study highlights the role of artificial intelligence in prostate cancer management Dr. Kamal Kant Kohli28 Aug 2025 8:00 PM ISTCancer is a significant global health issue affecting millions worldwide. Among the different types of cancer, prostate cancer (PCa)-which affects the...
Cancer Burden Analysis Across 43 Cancer Registries in India: 5 Key Highlights Dr Jeegar Dattani28 Aug 2025 7:00 AM ISTA large cross-sectional study has revealed significant regional disparities in cancer incidence across India and an overall rising cancer burden. The...
Bayer Gets CDSCO Committee Nod to Manufacture, Market Darolutamide 300 mg for mHSPC, PMS Study Mandated Susmita Roy18 Aug 2025 2:00 PM ISTNew Delhi: Bayer Pharmaceuticals has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...
Not all low-grade prostate cancers are low risk: JAMA Dr. Kamal Kant Kohli5 Aug 2025 8:30 PM ISTA new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results...
Polygenic Risk Score Outperforms PSA and MRI in Detecting Clinically Significant Prostate Cancer: NEJM Dr Riya Dave28 July 2025 8:15 PM ISTResearchers have found in a new BARCODE1 study that a polygenic risk score identified a higher proportion of clinically significant prostate cancer...
Bayer Nubeqa gets EU nod in third indication for advanced prostate cancer Ruchika Sharma22 July 2025 10:30 AM ISTBerlin: Bayer has received marketing authorization from the European Commission in the European Union (EU) for Nubeqa (darolutamide), an oral...
Biocon Biologics gets marketing nods in UK for Vevzuo, Evfraxy Ruchika Sharma7 July 2025 11:12 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has received marketing...
JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterations Ruchika Sharma6 July 2025 12:30 PM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced the submission of an extension of indication application...
